# Activated Recombinant Human Factor VII in Pelvic-acetabular Fracture Reconstruction

> **NCT01601457** · PHASE2 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 48 (actual)

## Conditions studied

- Acquired Bleeding Disorder
- Trauma

## Interventions

- **DRUG:** activated recombinant human factor VII
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01601457
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2004-04
- **Final completion:** 2004-04
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01601457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01601457, "Activated Recombinant Human Factor VII in Pelvic-acetabular Fracture Reconstruction". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01601457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*